Key facts
- This page summarizes Gregory H. Bailey's Form 4 filing for Serina Therapeutics, Inc. (SER).
- 2 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 24 May 2024, 16:15.
Gregory H. Bailey - 21 May 2024 Form 4 Insider Report for Serina Therapeutics, Inc. (SER)
- Reporting relationship
- Director
- Issuer ticker
- SER
- Reported as of
- 21 May 2024
- Net transaction value
- +$31,226
- SEC form
- 4
- Accepted by SEC
- 24 May 2024, 16:15:45 UTC
- Prior SEC filing
- 22 May 2024
- Next SEC filing
- 29 May 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Gregory Bailey
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Gregory H. Bailey filed Form 4 for Serina Therapeutics, Inc. (SER) on 24 May 2024.
Change
- Previous filing in this sequence was filed on 22 May 2024.
- Current net transaction value: +$31,226.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
SER
transaction
Common Stock
Purchase
- Transaction value
- $8,702
- Shares
- +916
- Change %
- +60%
- Price
- $9.50
- Shares after
- 2,438
- Date
- 21 May 2024
- Ownership
- Direct
SER
transaction
Common Stock
Purchase
- Transaction value
- $22,524
- Shares
- +2,371
- Change %
- +97%
- Price
- $9.50
- Shares after
- 4,809
- Date
- 23 May 2024
- Ownership
- Direct
* marks a reported price that did not pass the local price check.